ReviewJournal of hematology & oncology2019

Clinical trials of dual-target CAR T cells, donor-derived CAR T cells, and universal CAR T cells for acute lymphoid leukemia.

Juanjuan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.